Dgr. Evans et al., SOMATIC MOSAICISM - A COMMON-CAUSE OF CLASSIC DISEASE IN TUMOR-PRONE SYNDROMES - LESSONS FROM TYPE-2 NEUROFIBROMATOSIS, American journal of human genetics, 63(3), 1998, pp. 727-736
Blood samples from 125 families with classic type 2 neurofibromatosis
with bilateral vestibular schwannomas were analyzed for mutations in t
he NF2 gene. Causative mutations were identified in 52 families. In fi
ve families, the first affected individual in the family (the index ca
se) was a mosaic for a disease-causing mutation. Only one of nine chil
dren from the three mosaic cases with children are affected. Four of t
hese nine children inherited the allele associated with the disease-ca
using mutation yet did not inherit the mutation. NF2 mutations were id
entified in only 27/79 (34%) of sporadic cases, compared with 25/46 (5
4%) of familiar cases (P < .05). In 48 families in which a mutation ha
s not been identified, the index cases have had 125 children, of whom
only 29 are affected with NF2 and of whom only a further 21 cases woul
d be predicted to be affected by use of life curves. The 50/125 (40%)
of cases is significantly less than the 50% expected eventually to dev
elop NF2 (P < .05). Somatic mosaicism is likely to be a common cause o
f classic NF2 and may well account for a low detection rate for mutati
ons in sporadic cases. Degrees of gonosomal mosaicism mean that recurr
ence risks may well be < 50% in the index case when a mutation is not
identified in lymphocyte DNA.